⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL614543 | 0.98 | TAAR1 (0.47) | — | |
| Bromide SCHEMBL1423332 | 0.98 | HRH3 (0.44) | — | |
| SCHEMBL9500613 | 0.88 | NOS3 (0.41) | — | |
| SCHEMBL14886894 | 0.86 | L3MBTL1 (0.40) | — | |
| Fumaric Acid SCHEMBL27205408 | 0.84 | ALDH1A1 (0.37) | — | |
| Trifluoroacetic Acid SCHEMBL19816089 | 0.84 | LMNA (0.36) | — | |
| SCHEMBL31364603 | 0.83 | ALDH1A1 (0.31) | — | |
| SCHEMBL31364605 | 0.83 | ALDH1A1 (0.31) | — | |
| SCHEMBL2893056 | 0.80 | HRH4 (0.38) | — | |
| SCHEMBL11289554 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1543 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| CN-118725014-A | Mitochondrial targeting peptides | 隐形生物治疗公司 | 2024-10-01 | — | — | CN | claimed |
| CN-118702767-A | Mitochondrial targeting peptides | 隐形生物治疗公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118702766-A | Mitochondrial targeting peptides | 隐形生物治疗公司 | 2024-09-27 | — | — | CN | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| US-20240277668-A1 | HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS | TSP THERAPEUTICS INC. | 2024-08-22 | — | — | US | claimed |
| US-20240269123-A1 | MUSCLE REGENERATION PROMOTER | SATO PHARMACEUTICAL CO., LTD. (JP) | 2024-08-15 | — | — | US | claimed |
| US-20240219399-A1 | DIFFERENTIAL DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME | IMMUNDIAGNOSTIK AG (DE) | 2024-07-04 | — | — | US | claimed |
| EP-4376835-A1 | HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS | TSP Therapeutics Inc. (US) | 2024-06-05 | — | — | EP | claimed |
| US-20240165082-A1 | ORALLY ADMINISTERED COMPOSITIONS FOR CANCER TREATMENT | TSP THERAPEUTICS INC. | 2024-05-23 | — | — | US | claimed |
| EP-1200074-A2 | USE OF DIPHENYLIODONIUM FOR THE ACTIVATION AND PROTECTION OF CYTOTOXIC LYMPHOCYTES | Maxim Pharmaceuticals, Inc. (US) | 2002-05-02 | — | — | EP | claimed |
| WO-2001006756-A2 | USE OF DIPHENYLIODONIUM FOR THE ACTIVATION AND PROTECTION OF CYTOTOXIC LYMPHOCYTES | MAXIM PHARMACEUTICALS, INC. (US) | 2001-01-25 | — | — | WO | claimed |
| US-6028095-A | Treatment of inflammatory bowel disease using histamine H3 -receptor agonists | WARNER-LAMBERT COMPANY (US) | 2000-02-22 | — | — | US | claimed |
| EP-0748217-A1 | COMPOSITIONS COMPRISING A MAST CELL DEGRANULATION-BLOCKING AGENT FOR TREATMENT OF ENDOGENOUS, PAINFUL GASTROINTESTINAL CONDITIONS OF NON-INFLAMMATORY, NON-ULCERATIVE ORIGIN | KOS PHARMACEUTICALS, INC. (US) | 1996-12-18 | — | — | EP | claimed |
| WO-1995021611-A2 | COMPOSITIONS COMPRISING A MAST CELL DEGRANULATION-BLOCKING AGENT FOR TREATMENT OF ENDOGENOUS, PAINFUL GASTROINTESTINAL CONDITIONS OF NON-INFLAMMATORY, NON-ULCERATIVE ORIGIN | KOS PHARMACEUTICALS, INC. (US) | 1995-08-17 | — | — | WO | claimed |
| EP-0612525-A1 | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-08-31 | — | — | EP | claimed |
| EP-0214058-B1 | PHARMACEUTICAL COMPOSITION CONTAINING HISTAMINE DERIVATIVES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1992-05-06 | — | — | EP | claimed |
| EP-0214058-A2 | Pharmaceutical composition containing histamine derivatives | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1987-03-11 | — | — | EP | claimed |
| EP-0209586-A1 | ANTI-HISTAMINE ANTIBODY PREPARATION WITH SPECIFICITY FOR A 4-(2-AMINOETHYL)IMIDAZOLYL GROUP ATTACHED DIRECTLY TO AN ALKYLENE CHAIN AND IMMUNOASSAY METHOD EMPLOYING THE PREPARATION. | PHARMACIA AB (SE) | 1987-01-28 | — | — | EP | claimed |
| WO-1986004420-A1 | ANTIBODY PREPARATION WITH SPECIFICITY FOR ALIPHATICALLY BOUND 4-(2-AMINOETHYL)IMIDAZOLYL GROUP, MANUFACTURE AND USE OF THE ANTIBODY PREPARATION | PHARMACIA AB (SE) | 1986-07-31 | — | — | WO | claimed |